Clinical research: congenital heart disease/DOCHEAD>
Phospholipid abnormalities in children with Barth syndrome

https://doi.org/10.1016/j.jacc.2003.06.015Get rights and content
Under an Elsevier user license
open archive

Abstract

Objectives

We sought to identify characteristic lipid abnormalities in patients with Barth syndrome (BTHS) and to correlate the lipid profile to phenotype and genotype.

Background

Barth syndrome typically includes cardiomyopathy, skeletal myopathy, neutropenia, growth retardation, and 3-methylglutaconic aciduria, and it is commonly associated with mutations in the tafazzin (TAZ) gene, whose products are homologous to phospholipid acyltransferases. However, clinical features of BTHS have also been found in patients with normal TAZgene.

Methods

We analyzed molecular species of phospholipids in left and right ventricle, skeletal muscle, platelets, lymphoblasts, and fibroblasts from 19 children with BTHS (positive TAZmutation), 6 children with BTHS-like syndromes (wild-type TAZ), 4 children with isolated cardiomyopathy (wild-type TAZ), and various controls.

Results

Cardiolipin, the specific lipid found only in mitochondria, was decreased in all tissues from BTHS patients, whereas concentrations of other phospholipids were normal. The molecular composition of cardiolipin was altered in all tissues from BTHS patients. The molecular compositions of phosphatidylcholine and phosphatidylethanolamine were altered in the heart. Cardiolipin abnormalities were only found in children with true BTHS, not in children with BTHS-like disease or with isolated cardiomyopathy. The degree of cardiolipin deficiency was tissue-specific but did not correlate with severity or specific phenotypic expression of BTHS.

Conclusions

Abnormal cardiolipin is a specific diagnostic marker of cardiomyopathies caused by TAZmutations. These mutations lead to alterations in the fatty acid composition of several phospholipids, supporting the idea that TAZencodes a human acyltransferase.

Abbreviations

BTHS
Barth syndrome
DCM
dilated cardiomyopathy
HPLC
high-performance liquid chromatography
ICM
ischemic cardiomyopathy
LV
left ventricle
RV
right ventricle
TAZ
tafazzin

Cited by (0)

This work was supported by a grant-in-aid from the American Heart Association.